Andrew Derodra - Skyepharma
And finally this week, Andrew Derodra has been appointed Chief Financial Officer and an Executive Director at Skyepharma.
He joins the firm from Tate & Lyle, and has previously spent 23 years in senior finance roles at companies including SABMiller, Diageo, British Airways and Reed Elsevier.
“Andrew brings a broad range of business experience and I look forward to working with him as we leverage our strong platform for future growth and continue to create value for our shareholders,” said Skyepharma CEO Peter Grant.